Momet-F Inhaler (200 mcg+5 mcg)/puff is a combination inhalation therapy containing Mometasone Furoate and Formoterol Fumarate, designed for the long-term management of asthma and other obstructive airway conditions. This dual-action inhaler combines a corticosteroid with a long-acting bronchodilator to provide both anti-inflammatory control and sustained airway relaxation.

Momet-F Inhaler helps reduce airway inflammation, prevent asthma symptoms, and improve breathing capacity. It is intended for regular maintenance therapy and not for the relief of acute bronchospasm.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

• Corticosteroid + Long-Acting Beta2-Agonist (LABA)

• Anti-asthmatic Combination Therapy

Indications

Momet-F Inhaler is indicated for:

• Maintenance treatment of asthma

• Prevention of asthma symptoms such as wheezing, breathlessness, chest tightness, and coughing

• Long-term control of airway inflammation

• Patients not adequately controlled on inhaled corticosteroids alone

• Patients requiring combination therapy for improved symptom control

Pharmacology

Momet-F Inhaler contains two active components with complementary mechanisms:

Mometasone Furoate is a potent inhaled corticosteroid that reduces airway inflammation by inhibiting inflammatory mediators and suppressing immune responses in the respiratory tract. This decreases airway swelling, mucus production, and hyper-responsiveness.

Formoterol Fumarate is a long-acting beta2-adrenergic agonist (LABA) that stimulates beta2 receptors in bronchial smooth muscle, leading to relaxation of the airways. It provides rapid onset and prolonged bronchodilation, lasting up to 12 hours.

Together, these agents improve lung function, reduce exacerbations, and provide sustained asthma control.

Dosage and Administration

• Recommended dose: As prescribed by the physician based on severity of asthma

• Common dosage: 1–2 puffs twice daily

• Inhale through the mouth using proper inhaler technique

• Rinse mouth with water after each use to reduce the risk of oral fungal infection

• Not intended for acute asthma attacks; a rescue inhaler should be used for sudden symptoms

Patients should follow their healthcare provider’s instructions carefully and not exceed the recommended dose.

Side Effects

Common side effects may include:

• Hoarseness

• Sore throat

• Oral candidiasis (thrush)

• Headache

• Tremor

Less common but serious side effects:

• Paradoxical bronchospasm

• Palpitations

• Hypersensitivity reactions

• Adrenal suppression with prolonged high-dose use

Contraindications

• Hypersensitivity to Mometasone, Formoterol, or any component of the inhaler

• Primary treatment of status asthmaticus or acute asthma episodes

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions & Warnings

• Not a rescue medication for acute bronchospasm

• Use caution in patients with cardiovascular disorders, hyperthyroidism, diabetes, or seizure disorders

• Monitor growth in pediatric patients

• Prolonged use may increase the risk of systemic corticosteroid effects

• Do not abruptly discontinue therapy without medical advice

Drug Interactions

• Beta-blockers may reduce the bronchodilatory effect

• Concomitant use with other LABAs is not recommended

• Caution with CYP3A4 inhibitors which may increase corticosteroid exposure

Storage

• Store below 30°C

• Protect from direct sunlight and moisture

• Keep out of reach of children

• Do not puncture or expose to excessive heat

Mode of Action

Momet-F Inhaler works by combining anti-inflammatory and bronchodilatory effects. Mometasone reduces airway inflammation, while Formoterol relaxes bronchial smooth muscle. This dual mechanism provides sustained control of asthma symptoms and improves overall respiratory function.